Fri, Aug 1, 2014, 1:36 PM EDT - U.S. Markets close in 2 hrs 24 mins


% | $
Click the to save as a favorite.

Halozyme Therapeutics, Inc. Message Board

  • gator444444 gator444444 Apr 15, 2013 10:44 AM Flag

    Baxter , Roche Et Al

    If we are concerned about the big Pharma vs the little HALO.. one positive way to look at is that the big pharma could buy out HALO for north of $13.00 a share and get HALO out of its way.

    Sentiment: Hold

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • The problem with Roche is that they have a history or trying to steal IP first, or work around without regard to patents. If that fails, they then come to the table. But, this can take years and much in legal fees. One has only to look at the history they had with IGEN years ago. They wanted IP of IGEN, but tried to steal first. When that didn't work and lawsuits followed, they tried to drive IGEN stock to zero by naked shorted. This is in transcripts of trial is not an opinion. They play hardball. IGEN's ceo would have none of it and spent millions of company money to defend his company. Eventually, after years, he forced ROCHE to buy igen at big premium.

9.28-0.46(-4.72%)1:35 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.